S hef-1. S hef-4. S hef-5. S hef-7. H7. H1. 4. H. 181. I3. P ool ly mphoc ytes. P ool neutrophils. Leuc oc ytes. F. 1. Leuc oc ytes. F. 2. Leuc oc ytes. F. 3. Leuc oc.
Figure S3. Neutralization titres against H1N1pdm. The location of each pie chart indicates neutralization tire at baseline (x-axis) and at follow-up (y-axis).
Methylation sensitive enzymes cleave the amplicon at 11 sites: 60°C. BstUI cleaves at CGCG. 5 cuts at bases 43, 81, 93, 95, 105. 37°C. HhaI cleaves at GCGC.
Page 1. 0. 10. 20. 30. 40. 50. 60. 70. HIF004Bay x. HIF004Sha. R e la tive. P rim a ry R o o t le n g th. (%. ) HIF004Bay. HIF004Sha a a b. Figure S3.
Figure S3. 4.%. TEM. HIC PTC HIC. | p=0.002. TIM. РТС. РТС ÐÐС. TCM. 1 E + F T T + + P T T T + E + F = F = | ? 1 : 0 I T = T T T I C 1 C 1 T T T Ft T + T + 1.
Figure S3. (A) rs12150660. (B) rs6258. (C) rs5934505. GOOD. HH. FHS. H. H. H. SHIP. HH. Discovery. ÐÐÐС. HH. InCHIANTI. HH. RS1. KORA. MrOS Sweden.
Mobility of TTDA with and without actD. 0. 10. 20. 30. 40. 50. 0.4. 0.6. 0.8. 1.0. Time (sec.) R e la tiv e flu o rescenc e. Figure S3.
FIGURE S3. Homer la Knockout. Oh. 48 h. 200%. |. UH. NREM Delta %. Days. 20 IL. 09%. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15. Interval. --WT HE HET O-KO.
Figure S3: Detection of transcripts displaying circadian accumulation profiles in mice fed with normal chow (-Dox). A) Phase map of the 131 hepatic feature sets ...
DQ138152 VIET NAMA/CHICKEN/VIET NAM/TG-023/2004 GALLIFORMES. DQ138153 VIET NAM A/CHICKEN/VIETNAM/LA-024/2004 GALLIFORMES.
Supplementary Figure 3. Conserved domains among class III heme-peroxidases. Amino acid sequence alignment of POX12 with selected members of secreted ...
Shapiro-Wilk P= 0.597. Shapiro-Wilk P=0.685. Acetate.obs. Ethanol.obs. 0.04. 0.05. 0.00. O. O. O. Oo oo. O. -0.05. -0.04. TITI. -1.5 -0.5 0.5 1.5. Shapiro-Wilk P= ...
221. HAALSS. --CDP S. SVNV SEL HHTASPS-S. hTRNâSR1. 223 K A. DK-- N ... A HL. S D QR к ÑÑн. V. T E YD-. QYI R. SY P NEKQS VLPR-. â YQES KA SDI.
C. D. 1. 4. /1. 9. A le x a. -7. 0. 0. 0. 0. 50K. 100K. 150K. 200K. 250K. SSC-A. 85.5. 0. 10 3. 10 4. 10 5. C. D. 3. A. P. C. -H. 7. 0. 50K. 100K. 150K. 200K. 250K.
FIGURE S3 perinuclear region lamellar region. (μ m. 2. ) 10-3. 10-2. 10-1. 100. 10-3. 10-2. 10-1. 100. Time Lag, Ï (s). 10-1. 100. 101.
3. U. S-2. 4. U. S-2. 5. U. S-2. 6. Figure S3. SNP position. (in kb). 18 010. A G G G G G G G G G G G G G G G G G G G G G G G G G G G G G G G G G G A ...
PB S D. FIGURE S3. DEX/PBS DEX/rIL-21. rIL-Zl. W. N in. ETP n=3/gr0up m 2 0 .DN2 P< 0.05 a). $3â 1.5 i u. 2 1.0. 51. 0.5. 0. D 70 n=3/gr0up E 70 UDN3 n=3/ ...
Figure S3. Viral and target gene siRNAs in CaLCuV::Chl virus-infected wild type (Col-0) plants. (A) The 1961 bp ChlI-2 genomic locus is shown schematically ...
Page 1. S3 Figure. Lymphocytes. 42.6. FSC-A. S. S. C-A. Single Cells. 98.9. FSC-A. F. S. C-H. CD4+. 56.0. CD8+. 28.5. CD4 BV510. CD8 P. erCP. -Cy5.5.
Figure S3: Matriptase (MT-SP1) protein levels in the 4T1 MT-SP1 A cells and in the subpopulation of these cells that spontaneously reverted to a âflatâ ...
Figure S3
A
B
C
Initial Reverted
MT-SP1
Actin
Figure S3: Matriptase (MT-SP1) protein levels in the 4T1 MT-SP1 A cells and in the subpopulation of these cells that spontaneously reverted to a “flat” morphology. (A) Bright field image of the initial 4T1 MT-SP1 A cells. (B) Bright field image of the “flat” morphology subpopulation established from 4T1 MT-SP1 A clone. (C) Western blot showing matriptase levels in the initial 4T1 MT-SP1 A cells (Initial) and in 4T1 MT-SP1 A cells that reverted to a “flat” phenotype (Reverted). Actin represents the loading control. Note that we purposefully overloaded the “Reverted” line to underline the decrease in matriptase level. The 4T1 MT-SP1 A cells that reverted to a “flat” phenotype were established after multiple (>20) passages. They were split using 0.05% trypsin solution in PBS after a short wash (~1min) with low concentration (0.025%) trypsin in PBS to remove less adherent cells. The cells were split 1:16 every three days.
